GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
6V6W | Q2N0S9 | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 | |
6V74 | P14618 | Crystal Structure of Human PKM2 in Complex with L-asparagine | |
6V75 | P14618 | Crystal Structure of Human PKM2 in Complex with L-aspartate | |
6V76 | P14618 | Crystal Structure of Human PKM2 in Complex with L-valine | |
6V7N | P38571 | Crystal Structure of a human Lysosome Resident Glycoprotein, Lysosomal Acid Lipase, and its Implications in Cholesteryl Ester Storage Disease (CESD) | |
6V7Y | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
6V7Y | 6V7Y | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
6V7Y | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
6V7Y | 6V7Y | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
6V7Y | P61769 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 | |
6V7Z | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
6V7Z | 6V7Z | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
6V7Z | P15813 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
6V7Z | 6V7Z | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
6V7Z | P61769 | Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 | |
6V80 | P15813 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | 6V80 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | P15813 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | 6V80 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | P61769 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | K7N5M3 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | A0A0B4J240 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V80 | K7N5M4 | Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12 | |
6V81 | P76115 | The crystal structure of the outer-membrane transporter YncD | Probable TonB-dependent receptor YncD |
6V82 | O84173 | Crystal structure of tryptophan synthase from Chlamydia trachomatis D/UW-3/CX | |
6V82 | O84172 | Crystal structure of tryptophan synthase from Chlamydia trachomatis D/UW-3/CX | |
6V8Q | P40709 | Structure of an inner membrane protein required for PhoPQ regulated increases in outer membrane cardiolipin | |
6V8X | Q2N0S6 | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | Q2N0S9 | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | Q6N095 | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | 6V8X | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | Q6N095 | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | 6V8X | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | Q6PIL8 | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8X | Q6PIL8 | VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL |
6V8Z | Q2N0S6 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q2N0S7 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | P0DOX5 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | 6V8Z | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | P0DOX5 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | 6V8Z | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q6N089 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q6N089 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q8N5F4 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q8N5F4 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q6P5S8 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q6P5S8 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V9U | Q9NR97 | Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 14c | |
6VBG | C6FW78 | Lactose permease complex with thiodigalactoside and nanobody 9043 | |
6VBG | 6VBG | Lactose permease complex with thiodigalactoside and nanobody 9043 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024